Mutations at nucleotides 573 and 579 within 5′-untranslated region augment the virulence of coxsackievirus B1

Virus Research

Volumn 135, Issue 2, 2008, Pages 255-259

  Zhong, Zhaohua ^a   Li, Xiaobo ^a   Zhao, Wenran ^a   Tong, Lei ^a   Liu, Jian ^a   Wu, Shuaiqin ^a   Lin, Lexun ^a   Zhang, Zhonghai ^a   Tian, Ye ^a   Zhang, Fengmin ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

5 Untranslated region; Coxsackievirus B1; Mutation; Pathogenesis; Virulence

Indexed keywords

NUCLEOTIDE DERIVATIVE;

5' UNTRANSLATED REGION; AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS; COXSACKIE VIRUS B1; CYTOPATHOGENIC EFFECT; HELA CELL; HUMAN; HUMAN CELL; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; VIRUS REPLICATION; VIRUS VIRULENCE;

5' UNTRANSLATED REGIONS; ANIMALS; ANIMALS, SUCKLING; BASE SEQUENCE; ENTEROVIRUS B, HUMAN; HELA CELLS; HUMANS; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; MUTATION; VIRULENCE;

COXSACKIEVIRUS; MUS;

EID: 45449086445     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2008.04.012     Document Type: Article

References (23)

1. Archard L.C., Khan M.A., Soteriou B.A., Zhang H., Why H.J., Robinson N.M., and Richardson P.J. Characterization of Coxsackie B virus RNA in myocardium from patients with dilated cardiomyopathy by nucleotide sequencing of reverse transcription-nested polymerase chain reaction products. Hum. Pathol. 29 (1998) 578-584
2. Baboonian C., Davies M.J., Booth J.C., and McKenna W.J. Coxsackie B viruses and human heart disease. Curr. Top. Microbiol. Immunol. 223 (1997) 31-52
3. Bowles N.E., Richardson P.J., Olsen E.G., and Archard L.C. Detection of Coxsackie-B-virus-specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy. Lancet 1 (1986) 1120-1123
4. Brown E.A., Zajac A.J., and Lemon S.M. In vitro characterization of an internal ribosomal entry site (IRES) present within the 5′ nontranslated region of hepatitis A virus RNA: comparison with the IRES of encephalomyocarditis virus. J. Virol. 68 (1994) 1066-1074
5. Dunn J.J., Chapman N.M., Tracy S., and Romero J.R. Genomic determinants of cardiovirulence in coxsackievirus B3 clinical isolates: localization to the 5′ nontranslated region. J. Virol. 74 (2000) 4787-4794
6. Gan W., LaCelle M., and Rhoads R.E. Functional characterization of the internal ribosome entry site of eIF4G mRNA. J. Biol. Chem. 273 (1998) 5006-5012
7. Iizuka N., Yonekawa H., and Nomoto A. Nucleotide sequences important for translation initiation of enterovirus RNA. J. Virol. 65 (1991) 4867-4873
8. Ishii T., Shiroki K., Iwai A., and Nomoto A. Identification of a new element for RNA replication within the internal ribosome entry site of poliovirus RNA. J. Gen. Virol. 80 (1999) 917-920
9. Jang S.K., Davies M.V., Kaufman R.J., and Wimmer E. Initiation of protein synthesis by internal entry of ribosomes into the 5′ nontranslated region of encephalomyocarditis virus RNA in vivo. J. Virol. 63 (1989) 1651-1660
10. Jang S.K., Kräusslich H.G., Nicklin M.J., Duke G.M., Palmenberg A.C., and Wimmer E. A segment of the 5′ nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J. Virol. 62 (1988) 2636-2643
11. Kong W.P., Ghadge G.D., and Roos R.P. Involvement of cardiovirus leader in host cell-restricted virus expression. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 1796-1800
12. Kuethe F., Sigusch H.H., Hilbig K., Tresselt C., Glück B., Egerer R., and Figulla H.R. Detection of viral genome in the myocardium: lack of prognostic and functional relevance in patients with acute dilated cardiomyopathy. Am. Heart J. 153 (2007) 850-858
13. La Monica N., Meriam C., and Racaniello V.R. Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing. J. Virol. 57 (1986) 515-525
14. Liu Z., Carthy C.M., Cheung P., Bohunek L., Wilson J.E., McManus B.M., and Yang D. Structural and functional analysis of the 5′ untranslated region of coxsackievirus B3 RNA: In vivo translational and infectivity studies of full-length mutants. Virology 265 (1999) 206-217
15. Meerovitch K., Nicholson R., and Sonenberg N. In vitro mutational analysis of cis-acting RNA translational elements within the poliovirus type 2 5′ untranslated region. J. Virol. 65 (1991) 5895-5901
16. M'hadheb-Gharbi M.B., Paulous S., Aouni M., Kean K.M., and Gharbi J. The substitution U475 → C with Sabin3-like mutation within the IRES attenuate Coxsackievirus B3 cardiovirulence. Mol. Biotechnol. 36 (2007) 52-60
17. Minnich L.L., and Ray C.G. Variable susceptibility of mice to group B coxsackievirus infections. J. Clin. Microbiol. 11 (1980) 73-75
18. Racaniello V.R. Picornaviridae: the virus and their replication. In: Fields B.N., Knipe D.M., Howley P.M., and Griffin D.E. (Eds). Fields Virology. Fourth ed. (2001), Lippincott Williams & Williams, Philadelphia 685-722
19. Rinehart J.E., Gómez R.M., and Roos R.P. Molecular determinants for virulence in coxsackievirus B1 infection. J. Virol. 71 (1997) 3986-3991
20. Satoh M., Tamura G., Segawa I., Hiramori K., and Satodate R. Enteroviral RNA in dilated cardiomyopathy. Eur. Heart J. 15 (1994) 934-939
21. Tracy S., and Drescher K.M. Coxsackievirus infections and NOD mice: relevant models of protection from, and induction of, type 1 diabetes. Ann. NY Acad. Sci. 1103 (2007) 143-151
22. Whitton J.L., Cornell C.T., and Feuer R. Host and virus determinants of picornavirus pathogenesis and tropism. Nat. Rev. Microbiol. 3 (2005) 765-776
23. Yang D., Wilson J.E., Anderson D.R., Bohunek L., Cordeiro C., Kandolf R., and McManus B.M. In vitro mutational and inhibitory analysis of the cis-acting translational elements within the 5′ untranslated region of coxsackievirus B3: potential targets for antiviral action of antisense oligomers. Virology 228 (1997) 63-73